| Secondary |
| Product Used For Unknown Indication |
30.3% |
| Drug Use For Unknown Indication |
13.7% |
| Depression |
12.0% |
| Hypertension |
8.6% |
| Cancer Pain |
6.9% |
| Cardiac Failure |
3.4% |
| Haematuria |
3.4% |
| Dizziness |
2.9% |
| Drug Exposure During Pregnancy |
2.3% |
| Dyspepsia |
2.3% |
| Atrial Fibrillation |
1.7% |
| Cystitis |
1.7% |
| Epilepsy |
1.7% |
| Prophylaxis Of Nausea And Vomiting |
1.7% |
| Thyroid Disorder |
1.7% |
| Anxiety |
1.1% |
| Asthma |
1.1% |
| Neuralgia |
1.1% |
| Psychotic Disorder |
1.1% |
| Type 1 Diabetes Mellitus |
1.1% |
|
| Pneumonia Aspiration |
12.1% |
| Toxic Epidermal Necrolysis |
9.1% |
| Hypokalaemia |
6.1% |
| Orthostatic Hypotension |
6.1% |
| Pancreatitis Relapsing |
6.1% |
| Pulmonary Embolism |
6.1% |
| Pupils Unequal |
6.1% |
| Thrombocytopenia |
6.1% |
| Thyroid Disorder |
6.1% |
| Tumour Associated Fever |
6.1% |
| Agranulocytosis |
3.0% |
| Angioedema |
3.0% |
| Aphasia |
3.0% |
| Drug Exposure During Pregnancy |
3.0% |
| Headache |
3.0% |
| Hepatic Enzyme Increased |
3.0% |
| Hyperhidrosis |
3.0% |
| Hyperprolactinaemia |
3.0% |
| Metrorrhagia |
3.0% |
| Pain In Extremity |
3.0% |
|
| Concomitant |
| Depression |
20.4% |
| Drug Use For Unknown Indication |
20.4% |
| Product Used For Unknown Indication |
15.9% |
| Hypertension |
5.8% |
| Anxiety |
4.6% |
| Headache |
3.4% |
| Psoriasis |
3.0% |
| Schizophrenia |
3.0% |
| Epilepsy |
2.7% |
| Convulsion |
2.4% |
| Schizophrenia, Disorganised Type |
2.4% |
| Non-small Cell Lung Cancer |
2.1% |
| Prophylaxis |
2.1% |
| Osteoarthritis |
1.8% |
| Pneumonia |
1.8% |
| Vertigo |
1.8% |
| Asthmatic Crisis |
1.5% |
| Constipation |
1.5% |
| Convulsion Prophylaxis |
1.5% |
| Diabetes Mellitus |
1.5% |
|
| Loss Of Consciousness |
8.6% |
| Pancreatitis Acute |
8.6% |
| Small Cell Lung Cancer Metastatic |
6.9% |
| Vertigo |
6.9% |
| Viral Infection |
6.9% |
| Vomiting |
6.9% |
| Hyponatraemia |
5.2% |
| Respiratory Disorder |
5.2% |
| Spontaneous Haematoma |
5.2% |
| Tremor |
5.2% |
| Blood Immunoglobulin E Increased |
3.4% |
| Cholestasis |
3.4% |
| Drug Interaction |
3.4% |
| Fluid Retention |
3.4% |
| Hiccups |
3.4% |
| International Normalised Ratio Decreased |
3.4% |
| Ophthalmoplegia |
3.4% |
| Overdose |
3.4% |
| Palpitations |
3.4% |
| Personality Disorder |
3.4% |
|
